FDA Approves First Gene-Based Test to Detect the Spread of Breast Cancer Into Lymph N
 

Veridex, LLC, a Johnson & Johnson company, has announced U.S. Food and Drug Administration (FDA) approval of the first intra-operative and gene-based test to detect the spread of breast cancer into the lymph nodes.

More...